DR.Chip Biotechnology Incorporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was TWD 22.644 million compared to TWD 23.495 million a year ago. Operating loss was TWD 6.834 million compared to TWD 5.082 million a year ago. Net loss was TWD 5.682 million compared to TWD 3.443 million a year ago. Basic loss per share was TWD 0.12 compared to TWD 0.07 a year ago. For the half year, total revenue was TWD 43.753 million compared to TWD 51.645 million a year ago. Operating loss was TWD 17.543 million compared to TWD 10.242 million a year ago. Net loss was TWD 15.269 million compared to TWD 6.936 million a year ago. Basic loss per share was TWD 0.32 compared to TWD 0.14 a year ago.